Center Laboratories Management
Management criteria checks 4/4
Center Laboratories' CEO is Yvonne Wang, appointed in Oct 2023, has a tenure of 2.08 years. total yearly compensation is NT$5.84M, comprised of 98.6% salary and 1.4% bonuses, including company stock and options. directly owns 0.18% of the company’s shares, worth NT$49.13M. The average tenure of the management team and the board of directors is 2.9 years and 3.8 years respectively.
Key information
Yvonne Wang
Chief executive officer
NT$5.8m
Total compensation
| CEO salary percentage | 98.60% |
| CEO tenure | 2.1yrs |
| CEO ownership | 0.2% |
| Management average tenure | 2.9yrs |
| Board average tenure | 3.8yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2025 | n/a | n/a | NT$2b |
| Jun 30 2025 | n/a | n/a | -NT$668m |
| Mar 31 2025 | n/a | n/a | -NT$14m |
| Dec 31 2024 | NT$6m | NT$6m | -NT$1b |
| Sep 30 2024 | n/a | n/a | -NT$415m |
| Jun 30 2024 | n/a | n/a | -NT$2b |
| Mar 31 2024 | n/a | n/a | -NT$3b |
| Dec 31 2023 | NT$5m | n/a | -NT$995m |
Compensation vs Market: Yvonne's total compensation ($USD185.73K) is about average for companies of similar size in the TW market ($USD212.71K).
Compensation vs Earnings: Yvonne's compensation has been consistent with company performance over the past year.
CEO
Yvonne Wang
Ms. Su-Chi Wang, also known as Yvonne, is Director of Anya Biopharm Inc. She is Chairman of the Board Lumosa Therapeutics Co. Ltd. from May 14, 2024. Ms. Wang Serves as Chief Executive Officer, Operations...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Chief Investment Officer | 2.1yrs | NT$5.84m | 0.18% NT$ 49.1m | |
| Manager of Finance & Accounting Department | 2.9yrs | no data | no data | |
| Director of Administration Department | 27.3yrs | no data | no data | |
| Assistant Vice President of Legal Affairs Department | 2.8yrs | NT$2.30m | no data | |
| General President of Pharmaceutical Business | 2.1yrs | NT$3.47m | 0.69% NT$ 185.9m | |
| Head of Corporate Governance | no data | NT$1.87m | no data | |
| Plant Director | 8.8yrs | NT$2.28m | no data |
Experienced Management: 4123's management team is considered experienced (2.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Chief Investment Officer | 3yrs | NT$5.84m | 0.18% NT$ 49.1m | |
| Independent Director | 5.4yrs | NT$735.00k | no data | |
| Director | 5.4yrs | NT$50.00k | no data | |
| Director | 3.8yrs | no data | 0.30% NT$ 79.7m | |
| Director | 3.8yrs | no data | 0.72% NT$ 195.1m | |
| Director | 3.5yrs | NT$50.00k | no data | |
| Director | 3.8yrs | no data | no data | |
| Independent Director | 3.8yrs | NT$725.00k | no data |
Experienced Board: 4123's board of directors are considered experienced (3.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/25 19:04 |
| End of Day Share Price | 2025/11/25 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Center Laboratories, Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yenya Kuo | Capital Securities Corporation |
| Hsiu Chi Lin | Masterlink Securities Corp. |